Literature DB >> 8697309

Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.

A Calle-Pascual, J Garcia-Honduvilla, P J Martin-Alvarez, J R Calle, J P Maranes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8697309

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  8 in total

Review 1.  Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.

Authors:  R Rabasa-Lhoret; J L Chiasson
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

2.  Glucose supply and insulin demand dynamics of antidiabetic agents.

Authors:  Scott V Monte; Jerome J Schentag; Martin H Adelman; Joseph A Paladino
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

3.  "Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.

Authors:  Ken Yajima; Akira Shimada; Hiroshi Hirose; Akira Kasuga; Takao Saruta
Journal:  Rev Diabet Stud       Date:  2004-08-10

Review 4.  Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

Authors:  André J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Meta-analysis and critical review on the efficacy and safety of alpha-glucosidase inhibitors in Asian and non-Asian populations.

Authors:  Xueying Gao; Xiaoling Cai; Wenjia Yang; Yifei Chen; Xueyao Han; Linong Ji
Journal:  J Diabetes Investig       Date:  2017-08-17       Impact factor: 4.232

6.  Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.

Authors:  Xiaoling Cai; Xueyao Han; Yingying Luo; Linong Ji
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

7.  Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study.

Authors:  Feng-Fei Li; Xiao-Hua Xu; Li-Yuan Fu; Xiao-Fei Su; Jin-Dan Wu; Chun-Feng Lu; Lei Ye; Jian-Hua Ma
Journal:  Int J Endocrinol       Date:  2015-11-11       Impact factor: 3.257

8.  Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus.

Authors:  Chu Lin; Xiaoling Cai; Wenjia Yang; Fang Lv; Lin Nie; Linong Ji
Journal:  BMC Med       Date:  2020-11-16       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.